McKesson and CD&R take Option Care private for $5.8B
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion deal.
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion deal.
xAI, Intel, and Hugging Face led a $227 billion private equity and venture-backed exit market even as deal volume fell 17% globally.
GTCR completed an acquisition of Tactacam, a previously PE-backed action camera and dash cam manufacturer, in a deal valued over $1 billion.
Startale Japan launched Japan's first digital corporate bond paid entirely in JPYSC, a yen-denominated stablecoin, bringing blockchain-based settlement into real-world Japanese corporate finance.
The specialty foundry joint venture between VIS and NXP completed construction of Singapore's first 300mm semiconductor fabrication plant in 22 months and expects volume production in early 2027.
Markets are seeing an acceleration in both mainboard and SME IPO activity, with 20 new issues scheduled to open for subscription this week, while 16 SME offerings are projected to raise Rs 697 crore.
Oura Health, maker of smart rings for health tracking, postponed its $2.1 billion IPO that was scheduled to begin trading on Wednesday, citing market conditions.